Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

Study Explores the Role of Medical Affairs in Supporting a New Product Launch in the Oncology Therapeutic Area

By: PR Newswire Association LLC. - 06 Feb 2016

Back to overview list

CHAPEL HILL, N.C., Feb. 5, 2016 /PRNewswire/ -- In the pharmaceutical industry the medical affairs function plays a key role for a host of launch activities including the identification and engagement of key thought leaders. The importance of this launch activity is especially high in the oncology therapeutic area where most treating physicians are specialists.

To help companies focused on oncology therapies find better ways to utilize medical affairs to support product launches, research and consulting leader Best Practices, LLC undertook a primary research study that produced a report, "Best Practices and the Role of Medical Affairs in Oncology Launch Excellence." This study will help companies focused on oncology therapies find better ways to utilize medical affairs to develop successful launch strategies. The research delivers current data, insights and best practices in oncology launch excellence from medical affairs leaders at top biopharmaceutical companies.

This report will help oncology launch leaders better understand:

How medical affairs is involved in the launch process in leading Pharma and Biotech companies
Strategies for effective thought leader (TL) segmentation and relationship management
Challenges in managing successful medical affairs launch support
Industry drivers regarding new product commercialization
Critical strategies for allocating medical affairs launch budget effectively

For this study, Best Practices, LLC relied on data and interviews involving 11 executives from leading life sciences companies. The study analyzes companies that focus on oncology therapies.

To access the full 36-page report or to download a complimentary summary: http://www3.best-in-class.com/rr1409.htm.

For related research, visit our Best Practices, LLC Web site at www.best-in-class.com/.

ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis.

SOURCE Best Practices, LLC

Back to overview list

to the top ↑